(Q46237123)

20 December 2017

title

Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy (English)

1 reference

20 December 2017

author name string

Danielle N Margalit

1

1 reference

20 December 2017

Meera Sreedhara

2

1 reference

20 December 2017

Yu-Hui Chen

3

1 reference

20 December 2017

Paul J Catalano

4

1 reference

20 December 2017

Paul L Nguyen

5

1 reference

20 December 2017

Mehra Golshan

6

1 reference

20 December 2017

Beth A Overmoyer

7

1 reference

20 December 2017

Jay R Harris

8

1 reference

20 December 2017

Jane E Brock

9

1 reference

20 December 2017

publication date

7 September 2012

1 reference

20 December 2017

Annals of Surgical Oncology

published in

1 reference

20 December 2017

volume

20

1 reference

20 December 2017

issue

3

1 reference

20 December 2017

page(s)

811-818

1 reference

20 December 2017

Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas

cites work

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2640-8

Ductal carcinoma-in-situ: long-term results of breast-conserving therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2640-8

Ductal carcinomain situ with microinvasion. A curable entity using surgery alone without need for adjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2640-8

The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2640-8

Ductal Carcinoma In Situ With Microinvasion: Prognostic Implications, Long-Term Outcomes, and Role of Axillary Evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2640-8

Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2640-8

Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2640-8

Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2640-8

Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2640-8

High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2640-8

Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2640-8

Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2640-8

Microinvasive breast cancer and the role of sentinel node biopsy: an institutional experience and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2640-8

HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2640-8

Sentinel lymph node metastasis from mammary ductal carcinoma in situ with microinvasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2640-8

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2640-8

HER-2 testing in breast cancer using parallel tissue-based methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2640-8

10.1245/S10434-012-2640-8

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

Dimensions Publication ID

1017167308

0 references

1 reference

20 December 2017